Leucocyte and eosinophil counts predict progression‐free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition

JOURNAL ARTICLE published June 2018 in British Journal of Haematology

Research funded by Cologne Fortune Grant (181/2016)

Authors: Ida Hude | Stephanie Sasse | Paul J. Bröckelmann | Bastian von Tresckow | Jesko Momotow | Andreas Engert | Sven Borchmann